Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;12(1):14-20.

Implementation of a Pharmacist-Led Diabetes Management Protocol

Affiliations

Implementation of a Pharmacist-Led Diabetes Management Protocol

Lana T Al-Omar et al. Am Health Drug Benefits. 2019 Feb.

Abstract

Background: Little data exist regarding how pharmacist-led collaborative drug therapy management protocols are implemented in health systems. Barriers to collaborative drug therapy management protocol implementation exist, but they can be overcome by effective protocol education and communication, allowing pharmacists to manage more patients with chronic disease states, thereby enhancing quality health outcomes for patients and reducing health resource utilization.

Objective: To determine the preferred method of provider education regarding the implementation of a pharmacist-led type 2 diabetes collaborative drug therapy management protocol, and to assess pharmacist and provider satisfaction with the protocol implementation.

Methods: This single-center, prospective cohort study included pharmacists practicing within a pharmacist-led type 2 diabetes collaborative drug therapy management protocol, as well as providers practicing at 4 primary care clinics within a health system. All providers received an e-mail regarding education about the protocol. In addition, providers at 2 of the clinics received education about the protocol at a provider meeting, and providers at the other 2 clinics received a personalized provider report card. The personalized provider report card identified patients within the provider's panel who met criteria for referral to a pharmacist under the new protocol. The referred patients were tracked for 2 months, and provider and pharmacist satisfaction with the protocol were assessed.

Results: A total of 54 patients were referred for pharmacist management per the protocol. The majority (89%) of patients were referred by providers who received a personalized provider report card. Nearly all (96%) of the providers were satisfied with the protocol-driven services, and most (67%) pharmacists were satisfied with their role in managing patients with type 2 diabetes under the collaborative drug therapy management protocol.

Conclusion: The majority of patients with type 2 diabetes who were referred for pharmacist management per the protocol were referred by providers who received personalized provider report cards. Provider and pharmacist satisfaction with the new pharmacist-led protocol was high.

Keywords: collaborative drug therapy management; disease management protocol; pharmacist-led management; provider report card; type 2 diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Referrals by Intervention Type (N = 54)
Figure 2
Figure 2. Provider Satisfaction Survey Results
Figure 3
Figure 3. Pharmacist Satisfaction Survey Results
None

References

    1. Lefebvre AL, Zullo AR, Dapaah-Afriyie R, et al. Outcomes of a pharmacist-managed clinic for underserved persons with unmanaged type 2 diabetes mellitus. J Pharm Pract Res. 2018;48:65–71. - PMC - PubMed
    1. Snyder ME, Earl TR, Gilchrist S, et al. Collaborative drug therapy management: case studies of three community-based models of care. Prev Chronic Dis. 2015;12:E39 Erratum in: Prev Chronic Dis. 2015;12:E114. - PMC - PubMed
    1. Rochester CD, Leon N, Dombrowski R, Haines ST. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Am J Health Syst Pharm. 2010;67:42–48. - PubMed
    1. Hansen EA, Pietkiewicz JM, Blum BL. Evaluation of the feasibility and utility of a pharmacist-centered collaborative drug therapy management program for oncology-based symptom management. J Pharm Pract. 2016;29:206–211. - PubMed
    1. Woolf R, Locke A, Potts C. Pharmacist prescribing within an integrated health system in Washington. Am J Health Syst Pharm. 2016;73:1416–1424. - PubMed

LinkOut - more resources